<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">133725</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Cell technology</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Новости клеточных технологий</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Endothelial progenitor cells of the bone marrow are not involved in the processes of tumor angiogenesis and are not necessary for the growth of malignant neoplasms.</article-title><trans-title-group xml:lang="ru"><trans-title>Эндотелиальные клетки-предшественницы костного мозга не участвуют в процессах опухолевого ангиогенеза и не являются необходимыми для роста злокачественных новообразований</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sergeev</surname><given-names>V. S.</given-names></name><name xml:lang="ru"><surname>Сергеев</surname><given-names>В. С.</given-names></name></name-alternatives><email>bozo.ilya@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Plaksa</surname><given-names>I. L.</given-names></name><name xml:lang="ru"><surname>Плакса</surname><given-names>И. Л.</given-names></name></name-alternatives><email>bozo.ilya@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2008-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2008</year></pub-date><volume>3</volume><issue>3</issue><issue-title xml:lang="ru"/><fpage>19</fpage><lpage>21</lpage><history><date date-type="received" iso-8601-date="2023-01-25"><day>25</day><month>01</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-01-25"><day>25</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2008, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2008, Эко-Вектор</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/133725">https://genescells.ru/2313-1829/article/view/133725</self-uri><abstract xml:lang="ru"><p/></abstract><trans-abstract xml:lang="en"><p/></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Bergers G., Benjamin L. Тumorigenesis and the angiogenic switch. Nat. Rev. Cancer 2003; 3: 401-10.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ellis L., Нicklin D. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 2008; 8: 579-91.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Gao D., Nolan D., Мellick A. et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008; 319: 195-8.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Lyden D., Нattori К., Dias S. et al. Impaired recruitment of one-marrow-derived endothelial and hematopoietic precursor cells locks tumor angiogenesis and growth. Nat. Мed. 2001; 7: 1194-201.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Nolan D., Ciarrocchi A., Мellick A. et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 2007; 21: 1546-58.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Нattori К., Dias S., Нeissig B. et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis y recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Мed. 2001; 193: 1005-14.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Zhang F., Нackett N., Lam G. et al. Green fluorescent protein selectively induces НSP70-mediated up-regulation of COX-2 expression in endothelial cells. Blood 2003; 102: 2115-21.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Perry S., Zhao Y., Nie L. et al. Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance. Blood 2007; 110 (7): 2351-60.</mixed-citation></ref></ref-list></back></article>
